BeyondSpring to present at lung cancer conference
BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company, announced Monday its lead compound, Plinabulin, will be presented in two posters at the upcoming 16th World Conference on Lung Cancer (WCLC) in Denver. Read More »